Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM CONTAINING A HISTAMINE H2 RECEPTOR ANTAGONIST AND AN ANTACID
UndeterminedMA46713A
Owner:JOHNSON & JOHNSON CONSUMER INC
BICYCLIC THIAZINE AND OXAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
UndeterminedMA54101A
Owner:AMGEN INC
Benzoic acid, benzoic acid derivatives and heteroarylcarboxylic acid conjugates of oxymorphono, prodrugs, their manufacturing and use processes
UndeterminedMA40937A
Owner:ZEVRA THERAPEUTICS INC
Anti-myostatin antibodies, polypeptides containing FC region variants, and methods of use
UndeterminedMA41294A
Owner:CHUGAI PHARMA CO LTD
Monovalent bispecific dianticorporps capable of binding to B7-H3 and CD3 and their uses
UndeterminedMA42665A
Owner:MACROGENICS INC
AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
UndeterminedMA49402A
Owner:VOYAGER THERAPEUTICS INC
ANTIMICROBIAL COMPOSITIONS CONTAINING CANNABINOIDS
UndeterminedMA42268A
Owner:AXIM BIOTECHNOLOGIES INC
Substituted nucleosides, nucleotides and analogues thereof
UndeterminedMA41441A
Owner:ALIOS BIOPHARMA INC
Bispecific Anti-MUC16-CD3 Antibodies and Conjugates Anti-MUC16 Drug
ActiveMA46277A
Owner:REGENERON PHARMACEUTICALS INC
PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USES
UndeterminedMA54051A
Owner:BOEHRINGER INGELHEIM INT GMBH
METHOD FOR TREATING OR IMPROVING METABOLIC DISORDERS USING GASTRIC INHIBITOR PEPTIDE RECEPTOR BINDING PROTEINS (GIPR) IN COMBINATION WITH GLP-1 AGONISTS
UndeterminedMA44154A
Owner:AMGEN INC
METHOD FOR TREATMENT OF CANCER PATIENTS SUFFERING FROM SEVERE KIDNEY FAILURE
UndeterminedMA43977A
Owner:TAIHO PHARMA CO LTD
HETEROARYL COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC DISEASES
InactiveMA39688A
Owner:TAKEDA PHARMA CO LTD
Substituted pyrrolopyridines used as bromodomaine inhibitors
UndeterminedMA40943A
Owner:CONSTELLATION PHARMA INC +1
Methods and apparatus for elastic deactivation in a laminate
UndeterminedMA40230A
Owner:ANDREWS ROBERT E +4
Improved polyethyleneimine polyethyleneglycol vectors
UndeterminedMA39970A
Owner:ALEX LEVITZKI MANAGEMENT & HLDG LTD
DYNAMIC ADJUSTMENT METHOD FOR THE MANUFACTURE OF A HEAT-TREATED STEEL SHEET
ActiveMA47084A
Owner:ARCELORMITTAL SA
SYSTEM AND METHOD FOR DETECTING DEFECTS IN SPECULAR OR SEMI-SPECULAR SURFACES BY PHOTOGRAMMETRIC PROJECTION
UndeterminedMA43424A
Owner:UNIV DE ZARAGOZA
SULFONYLUREE COMPOUNDS AS INTERLEUKIN 1 ACTIVITY INHIBITORS
UndeterminedMA53170A
Owner:F HOFFMANN LA ROCHE & CO AG
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR
ActiveMA40596A
Owner:ACERTA PHARMA BV
VALVE DEVICE AND USE OF SUCH A VALVE DEVICE AS AN ANTI-SIPHON VALVE IN AN INTRAVENOUS SYSTEM
UndeterminedMA46141A
Owner:CYT0365 AB
SYSTEM INDICATING DIRECTION IN CABLE NETWORK PRODUCTION
UndeterminedMA51550A
Owner:ELOPAR ELEKTRIK & OTOMOTIV PARCALARI SANAYI & TICARET ANONIM SIRKETI
Compositions comprising a bacterial strain of the genus Megasphaera and their uses
Owner:4D PHARMA RES LTD
METHODS AND APPARATUS FOR ADMINISTRATING VACCINES AGAINST THE HEPATITIS B VIRUS (HBV)
UndeterminedMA51292A
Owner:ICHOR MEDICAL SYSTEMS INC +1
ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN WITH BREAST CANCER
UndeterminedMA54293A
Owner:RADIUS PHARMACEUTICALS INC
METHOD, DEVICE, AND APPARATUS FOR IMAGE IDENTIFICATION, AND DATA STORAGE MEDIUM
UndeterminedMA47512A
Owner:TENCENT TECHNOLOGY (SHENZHEN) CO LTD
Compositions in the form of an injectable aqueous solution comprising at least human insulin A21g and a prandial-acting glucagon suppressant
UndeterminedMA49678A
Owner:ADOCIA
Nut and non-dairy components with reduced trace element content, compositions comprising them, and their production processes
UndeterminedMA71424A
Owner:ELSE NUTRITION GH LTD
METHODS OF ADMINISTRATING BELUMOSUDIL IN COMBINATION WITH CYP3A INDUCERS AND / OR PROTON PUMP INHIBITORS
UndeterminedMA71431A
Owner:KADMON CORP LLC
VACUUM DEPOSIT INSTALLATION AND METHOD FOR COATING A SUBSTRATE
UndeterminedMA51144A
Owner:ARCELORMITTAL SA
Bis-heteroarylic alkoxy derivatives used as protein aggregation modulators
UndeterminedMA47369A
Owner:UCB BIOPHARMA SPRL
VEHICLE WINDSHIELD FOR HEAD-UP DISPLAY, VEHICLE INCORPORATING AND MANUFACTURING
UndeterminedMA45152A
Owner:SAINT GOBAIN VITRAGE SA
Anti-PD-1 antibodies, or their fragments, for the treatment of hepatitis B
UndeterminedMA45999A
Owner:ARBUTUS BIOPHARMA CORPORAT ION
CONVEYOR BELT TRANSPORT CARRIAGE, MOBILE CONVEYOR INSTALLATION COMPRISING SUCH A CARRIAGE, AND ASSOCIATED MOVEMENT METHOD
UndeterminedMA41012A
Owner:BRUNONE RENE
DOSING REGIMEN FOR THE USE OF LY3154207 IN THE TREATMENT OF DOPAMINERGIC CENTRAL NERVOUS SYSTEM DISORDERS
ActiveMA54530A
Owner:ELI LILLY & CO
RELAY AND POWER SUPPLY BATTERY CIRCUIT USING IT
UndeterminedMA50194A
Owner:WM SMART MOBILITY (SHANGHAI) CO LTD
OPHTHALMIC COMPOSITIONS COMPRISING CYCLODEXTRIN AS THE SOLE ACTIVE AGENT
UndeterminedMA44492A
Owner:WARNEFORD HEALTHCARE
METHOD AND DEVICE FOR EVALUATING MEASURED VALUES DETERMINED DURING THE PRACTICAL DRIVING OF A VEHICLE
ActiveMA55770A
Owner:IAV
Addition salts of (s)-2-(1-(6-amino-5-cyanopyrimidin-4-ylamino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[1,2-f][1,2,4]triazine-5-carbonitrile
UndeterminedMA39827A
Owner:ALMIRALL SA
HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS INFECTIONS
UndeterminedMA54560A
Owner:JANSSEN PHARMA NV
Factor XI Antibodies and Methods of Use
Owner:NOVARTIS AG
NANOPARTICULAR FORMULATIONS AND THEIR PRODUCTION AND USE PROCESSES
UndeterminedMA46474A
Owner:ABRAXIS BIOSCIENCE LLC
SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYL ACID
ActiveMA52556A
Owner:NOVO NORDISK AS
Peptide macrocycles against Acinetobacter baumannii
UndeterminedMA52352A
Owner:F HOFFMANN LA ROCHE & CO AG
METHOD FOR TREATING SUBJECTS SUFFERING FROM CONTUSIONS OF THE CENTRAL NERVOUS SYSTEM
UndeterminedMA55813A
Owner:BIOGEN CHESAPEAKE LLC
COMBINATION TREATMENT WITH A TLR7 AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR
UndeterminedMA52701A
Owner:F HOFFMANN LA ROCHE & CO AG
1,4,6-TRISUBSTITUTE-2-ALKYL-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS
UndeterminedMA47593A
Owner:MERCK PATENT GMBH
BATTERY EXPLOSION PREVENTION SYSTEM FOR REMOVABLE AND FIXED BATTERIES
UndeterminedMA71464A
Owner:AHUJA PULKIT
RSV Prefusion Protein F Unique Variable Domain Antibody
UndeterminedMA42246A
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES +3
BI-SPECIFIC ANTIGEN-BINDING MOLECULES ACTIVATING T LYMPHOCYTES ANTI-CEAXCD3
UndeterminedMA43025A
Owner:F HOFFMANN LA ROCHE & CO AG
WIND TURBINE BLADE PARTITION AND METHOD FOR INSTALLING A PARTITION IN A WIND TURBINE BLADE
UndeterminedMA56023A
Owner:LM WIND POWER AS
SYSTEM, METHOD AND COMPUTER PROGRAMS FOR LOCATING DENTAL IMPLANTS
UndeterminedMA52606A
Owner:ACCURATE FIT SL
CYCLIZED SULFAMOYLARYLAMIDE DERIVATIVES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
InactiveMA42292A
Owner:JANSSEN SCI IRELAND UC
Pharmaceutical formulations comprising vilanterol
UndeterminedMA39288A
Owner:ARVEN ILAC SANAYI VE TICARET
METHOD AND SYSTEM FOR ATMOSPHERE TREATMENT IN A STORAGE FACILITY FOR PLANT PRODUCTS WITH HIGH RELATIVE HUMIDITY
UndeterminedMA50890A
Owner:XEDA INTERNATIONAL SA
1,2,3-Substituted Triazoles Used as Selective NR2B NMDA Modulators
UndeterminedMA44008A
Owner:JANSSEN PHARMA NV
SUBSTITUTED NUCLEOSIDE ANALOGUES INTENDED FOR USE AS PRMT5 INHIBITORS
UndeterminedMA43671A
Owner:JANSSEN PHARMA NV
TREATMENT OF GASTRIC CANCER USING POLYTHERAPIES INCLUDING OXALIPLATINE, 5-FLUORURACIL (AND LEUCOVORIN) AND LIPOSOMAL IRINOTECAN
UndeterminedMA46709A
Owner:IPSEN BIOPHARM LTD
OCULAR FORMULATIONS ALLOWING MEDICATION ADMINISTRATION AND PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE
UndeterminedMA56220A
Owner:PANOPTICA INC
SOLIDIFICATION OF A NATURAL RUBBER LATEX BY POLYQUATERNARY POLYMERS
UndeterminedMA45989A
Owner:VERSALIS SPA
PROCESS FOR THE PRODUCTION OF FERTILIZER PARTICLES COMPRISING ALTERNATIVE SOURCES OF BORON
UndeterminedMA47586A
Owner:YARA INTERNATIONAL ASA
METHOD FOR MANUFACTURED A HIGH-STRENGTH STEEL SHEET AND SHEET OBTAINED ACCORDING TO THE METHOD
Owner:ARCELORMITTAL SA
MACHINE FOR THE CONTINUOUS PRODUCTION OF A CORRUGATED TUBE
UndeterminedMA43641A
Owner:ITIB MACHINERY INT SRL
THIENO[3,2-B]-PYRROLE[3,2-D]PYRIDAZINONES DERIVATIVES AND THEIR USE AS PKM2 DERIVATIVES FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH CANCER, OBESITY, AND DIABETES
UndeterminedMA54948A
Owner:AGIOS PHARMACEUTICALS INC
METHODS AND COMPOSITIONS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY
UndeterminedMA43377A
Owner:FRED HUTCHINSON CANCER RESEARCH CENTER +1
METHOD FOR TRANSFERRING STANDARDIZED CONTAINERS BETWEEN A CONTAINER SHIP AND A QUAY
UndeterminedMA44748A
Owner:RUIZ VEGA ANTONIO MARCOS
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTESTINAL INFLAMMATION AND COLON CANCER
UndeterminedMA47172A
Owner:UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INC
ORGANIC COMPOUNDS OF THE MONOBACTAM FAMILY FOR THE TREATMENT OF BACTERIAL INFECTIONS
InactiveMA39777A
Owner:NOVARTIS AG
ANTIBODIES AGAINST SIGNAL REGULATOR ALPHA PROTEIN AND METHODS OF USE
UndeterminedMA52091A
Owner:ALX ONCOLOGY INC
PHARMACEUTICAL COMBINATION INCLUDING A TYPE T CALCIUM CHANNEL BLOCKER
UndeterminedMA49114A
Owner:IDORSIA PHARMACEUTICALS LTD
POLYTHERAPY USING HUMAN DIFFERENCE AND GROWTH FACTOR 15 (GDF-15) INHIBITORS AND IMMUNE CHECKPOINT BLOCKERS
ActiveMA43035A
Owner:JULIUS MAXIMILIANS UNIV WURZBURG
MIXTURES AND COMPOSITIONS COMPRISING 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE AND THEIR METHODS OF USE
UndeterminedMA54148A
Owner:ADAMA MAKHTESHIM LTD
Energy efficient ethanol recovery by adsorption
UndeterminedMA39820A
Owner:JOULE UNLIMITED TECHNOLOGIES INC
MULTISPECIFIC IMMUNOMODULATOR ANTIGEN-BINDING CONSTRUCTIONS
UndeterminedMA43874A
Owner:COMPASS THERAPEUTICS LLC
PLANT PROTECTION COMPOSITIONS COMPRISING HERBIDICINES OF PYRIDINE CARBOXYLATE AND CLOQUINTOCET
UndeterminedMA54151A
Owner:CORTEVA AGRISCIENCE LLC
ISOINDOLINONE MDM2-P53 INTERACTION INHIBITORS WITH ANTICANCER ACTIVITY
UndeterminedMA43032A
Owner:ASTEX THERAPEUTICS LTD +1
PRODUCTION OF CAD-MGO BINDERS AND CONSTRUCTION PRODUCTS WITH REUSE OF BY-PRODUCTS AND / OR RESIDUES AND CARBON DIOXIDE ABSORPTION
UndeterminedMA53339A
Owner:UNIVERSIDADE DA BEIRA INTERIOR
Pyrrolotriazinone and imidazotriazinone derivatives as ubiquitin-specific protease inhibitors No. 7 (USP7) for the treatment of cancer
UndeterminedMA41291A
Owner:FORMA THERAPEUTICS INC
SUPPORT BASE FOR ATTACHING AN INTERIOR MIRROR BASE COVER TO A VEHICLE'S WINDSHIELD
ActiveMA53077A
Owner:PSA AUTOMOBILES SA
IMPROVING THE ANTI-CAKING PROPERTIES OF AMMONIUM NITRATE PARTICLES STORED IN A CLOSED CONTAINER
ActiveMA49446Apreventing and limiting amountimproved operation and uptime
Owner:YARA INTERNATIONAL ASA
ADC FOR TREATMENT CONCURRENT WITH OR SUBSEQUENT TO DOCETAXEL
UndeterminedMA55871A
Owner:PIERRE FABRE MEDICAMENT SAS
METHOD FOR DYNAMICALLY BALANCING A ROTATING BODY
UndeterminedMA55373A
Owner:BROSE FAHRZEUGTEILE GMBH & CO KG
HYDROMETALURGY PROCESS FOR PROCESSING ELECTRONIC BOARDS
UndeterminedMA50434A
Owner:SMART WASTE ENG SRL
MOBILE CABLE CONNECTION MODULE AND CABLE MAKING ASSEMBLY AND METHOD FOR CONNECTING A CABLE TO SUCH AN ASSEMBLY
UndeterminedMA71535A
Owner:KOMAX HOLDING
Viscoelastic plastic spacer for vibration-acoustic damping and glazing incorporating such a spacer
UndeterminedMA45726A
Owner:SAINT GOBAIN VITRAGE SA
PROCESS FOR THE MANUFACTURE OF HIGHLY POROUS CALCIUM HYDROXIDE
UndeterminedMA53760A
Owner:LHOIST RECH & DEV SA
QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3K INHIBITORS
UndeterminedMA45896A
Owner:JANSSEN PHARMA NV
RING-SHAPED WEARABLE DEVICES, SYSTEMS, AND THEIR METHODS OF USE
UndeterminedMA71702A
Owner:LOTUS LABORATORIES INC
Curtain wall and wall element used and method of manufacturing such a wall element
ActiveMA46577A
Owner:CLAEYS STEPHANIE CATHARINA R +2
PROCESS FOR PREPARATION OF N-(5-(3-(7-(3-FLUOROPHENYL))-3 H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-YL)PYRIDIN-3-YL)-3-METHYLBUTANAMIDE
ActiveMA45141A
Owner:BIOSPLICE THERAPEUTICS INC
IMPROVED PROCESS FOR THE PREPARATION OF AMINOPYRIMIDINE DERIVATIVES
ActiveMA49700A
Owner:YUHAN CORPORATION
Aromatic sulfonamide derivatives for the treatment of ischemic stroke
UndeterminedMA50448A
Owner:BAYER AG
MULTIMODAL SYSTEM FOR OBTAINING SENIOLOGICAL IMAGING USING RADIOGRAPHIC AND MBI TECHNIQUES
UndeterminedMA50469A
Owner:METALTRONICA SPA
APPARATUS FOR WELDING A TERMINAL TO A VEHICLE WINDOW AND RELATED METHOD
UndeterminedMA51225A
Owner:SAINT GOBAIN VITRAGE SA
MACROCYCLIC INHIBITORS OF PROTEIN-PROTEIN INTERACTIONS PD- / PD-L1 AND CD80(-1) / PD-L1
UndeterminedMA43774A
Owner:BRISTOL MYERS SQUIBB CO
Conjugates comprising cell-binding agents and cytotoxic agents
UndeterminedMA40415A
Owner:IMMUNOGEN INC
HETEROARYL DERIVATIVE, ITS PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITION INCLUDING IT AS AN EFFECTIVE CONSTITUENT
UndeterminedMA55380A
Owner:B2SBIO CO LTD +2
Cholesteryl ester vesicles loading peptides, proteins, and nucleic acids into chylomicrons and body cells
UndeterminedMA46058A
Owner:MCCOURT MARY P +2